(Q43832785)

27 November 2017

First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants (English)

1 reference

27 November 2017

3

Olivier Berton

1 reference

27 November 2017

Thomas Ryckmans

1

1 reference

27 November 2017

Laurent Balançon

2

1 reference

27 November 2017

Christophe Genicot

4

1 reference

27 November 2017

Yves Lamberty

5

1 reference

27 November 2017

Benedicte Lallemand

6

1 reference

27 November 2017

Patrick Pasau

7

1 reference

27 November 2017

Nathalie Pirlot

8

1 reference

27 November 2017

Luc Quéré

9

1 reference

27 November 2017

Patrice Talaga

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

27 November 2017

12

1 reference

27 November 2017

261-264

1 reference

27 November 2017

2

1 reference

Mirtazapine: a review of its use in major depression

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action: serotonin reuptake inhibition and 5-HT1A receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Design and synthesis of new potent, silent 5-HT1A antagonists by covalent coupling of aminopropanol derivatives with selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

The role of corticotropin-releasing factor in depression and anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Corticotropin-releasing hormone receptor antagonists: framework design and synthesis guided by ligand conformational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Substance P antagonists: the next breakthrough in treating depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Update on Substance P (NK-1 receptor) antagonists in clinical trials for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Novel strategies for pharmacotherapy of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Synthesis and structure-activity relationships of CP-122,721, a second-generation NK-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Characterization of [3H]paroxetine binding in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures(1).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

Activity of SR 142801 at peripheral tachykinin receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900727-2

7 January 2021

10.1016/S0960-894X(01)00727-2

Identifiers

DOI

1 reference

27 November 2017

1 reference